Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 341 of 341 publications.

Arana A, Wentworth CE, Conde E. Cancer incidence in patients with and without atopic dermatitis in the United Kingdom. Presented at the 23rd International Conference on Pharmacoepidemiology; 2007.

Arana A, Arellano FM, Wentworth CE. Cancer incidence in patients with and without atopic dermatitis in the United Kingdom. Presented at the Annual Meeting of the Society for Investigative Dermatology; 2007. Previously presented at the 23rd International Conference on Pharmacoepidemiology.

Arellano FM, Wentworth CE, Conde E, Schlienger R, Fernández-Vidaurre C, Arana A. Incidencia de cáncer en pacientes con y sin atópica dermatitis en Inglaterra. Presented at the VII Jornadas de Farmacovigilancia; 2007.

Arellano FM, Wentworth CE, Arana A, Fernández C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol. 2007;127(4):808-16.

Seeger JD, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2006 Dec 1;214(1):32-9.

Huerta C, Rivero E, Gil M, Garcia-Rodriguez LA. Incidence and natural history of psoriasis diagnosed in general practice. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S275-6.

Arellano FM, Wentworth CE, Arana A. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. Presented at the 22nd International Conference on Pharmacoepidemiology; August 2006. Lisbon, Portugal.

Colman S, Barrows SM, Nixon A, Nixon M, Taylor T, Atkinson M, Miller T. Validation of the hyperpigmentation treatment satisfaction questionnaire (HPTSQ). Presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.

Barrows SM, Colman SS, Nixon M, Nixon A, Taylor TN. Estimated prevalence of solar lentigines and melasma in the US population. Poster presented at the Annual Meeting of the American Academy of Dermatology; March 2006.

McKennas SP, Whalley D, deProst Y, Staab D, Huels J, Paul CF, vanAssche D. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life. J Eur Acad Dermatol Venereol. 2006 Mar 1;20(3):248-54.

Hampson NE, Meads DM, McKenna SP, Doward LC, Turk F. Factors influencing quality of life in atopic dermatitis. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A149.

Nijsten T, Whalley D, Gelfand J, Margolis D, McKenna SP, Stern RS. The psychometric properties of the psoriasis disability index in United States patients. J Invest Dermatol. 2005 Oct 1;125(4):665-72.

Colman SS, Nixon A, Barrows SM, Taylor TN, Miller T. Qualitative research methods: development of a hyperpigmentation treatment satisfaction with medication questionnaire. Poster presented at the Annual Meeting of the International Society for Quality of Life Research; October 2005.

Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005 Aug 1;153(2):372-7.

Meads DM, McKenna SP, Doward LC, Hampson N. Interpreting scores on the Quality of Life Index for Atopic Dermatitis (QoLIAD). Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):331-2.

McKenna SP, Whalley D, Dewar Al, Erdman RA, Kohlmann T, Niero M, Baro E, Cook SA, Crickx B. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res. 2005 Feb 1;14(1):231-41.

Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B, Iversen L, Johansen JD, Agner T. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol. 2005 Jan 1;152(1):93-8.

McKenna SP, Meads DM, Doward LC. Scaling properties of the Dermatology Life Quality Index (DLQI). Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):750-1.

Lanza L, Rivero Ferrer M, Fernández C, West WA, Seeger JD. Pregnancy incidence among women with inflammatory skin disorders. Poster presented at the 20th International Conference on Pharmacoepidemiology; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Aug; 13(Suppl 1):S206-7.

Whalley D, McKenna SP, Dewar Al, Erdman RA, Kohlmann T, Niero M, Cook SA, Crickx B, Herdman MJ. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004 Feb 1;150(2):274-83.

Brazier JE, Stevens KJ, McKenna SP, Doward LC. The valuation of atopic dermatitis health states in children. Poster presented at the 10th Annual Conference of the International Society for Quality of Life Research (ISQOL); November 2003. [abstract] Qual Life Res. 2003 Nov; 12(7):833.

McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, van Assche D. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003 Aug 1;149(2):323-31.

Rivero E, Huerta C, Garcia-Rodriguez LA, Fernandez-Vidaurre C, Abrams BB. The risk of lymphoid neoplasms and other hematological malignancies in patients with atopic dermatitis. Poster presented at the 19th International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(Suppl 1):S110-1.

Ellis CN, Mordin MM, Adler EY. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial. Am J Clin Dermatol. 2003 Feb 1;4(2):131-9.

McLeod LD, Fehnel SE, Brandman J, Symonds T. Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire. Pharmacoeconomics. 2003 Jan 1;21(15):1069-79.

Sánchez Matienzo D, Gimeno V, Castellsague J, Arana A. A comparative safety profile of serious skin and hypersensitivity reactions: cOX-s specific inhibitors vs. non-selective NSAIDs and other selected drugs. Presented at the 19th International Conference on Pharmacoepidemiology; 2003. [abstract] Pharmacoepidemiol Drug Saf. 2003; 12(S1):S185.

Fehnel SE, McLeod LD, Brandman J, Arbit DI, McLaughlin-Miley CJ, Coombs JH, Martin AR, Girman CJ. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002 Dec 1;11(8):809-16.

Whalley D, Huels J, McKenna SP, van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. Pediatrics. 2002 Dec 1;110(6):1133-6.

Castellsague J, García-Rodríguez LA, Duque A, Perez-Gutthann S. Risk of severe cutaneous disorders in users of oral antifungals. BMC Dermatology. 2002 Nov 28;2(14). doi: 10.1186/1471-5945-2-14

McLeod LD, Fehnel SE, Brandman J, Symonds T. Minimal clinically important differences on the acne-specific quality of life questionnaire (Acne-QoL). Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.

Menter A, Gottlieb A, Griffiths C, Mordin MM. Health-related quality of life impact of weekly intravenous or intramuscular alefacept in patients with psoriasis: results from two randomized, placebo-controlled phase III trials. Poster presented at the Annual Meeting of the American Academy of Dermatology; February 2002.

Castellsague J, Garcia-Rodriuez LA, Duque A, Perez S. Risk of serious skin disorders among users of oral antifungals: a population-based study. BMC Dermatology. 2002;2:14.

Fehnel SE, McLeod LD. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL). Poster presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2001.

McKenna SP, Cook SA, Whalley D, Doward LC, van Assche D. Testing the psychometric properties of the PSORIQoL: a psoriasis-specific quality of life instrument. Poster presented at the 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 2001. Amsterdam, The Netherlands. [abstract] Qual Life Res. 2001 Apr; 10(3):262.

Cook SA, Doward LC, McKenna SP, Erdman R, Niero M, van Assche D. Venous leg ulcers – patient-reported impact on quality of life. Proc Br Psychol Soc. 2001;9(1):64.

McKenna SP, Cook SA, Whalley D, Doward LC, Niero M, Erdman RA. The development of the PSORIQoL: a quality of life measure specific to psoriasis. Poster presented at the 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL); October 2000. Vancouver, Canada. [abstract] Qual Life Res. 2000 Mar; 9(3):322.

Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, Olsen J. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology. 2000 Mar;11(2):185-8.

Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, Demuro-Mercon C, Waldstreicher J. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996 Oct;5(5):481-90.

Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, Demuro-Mercon C. Development of an acne-specific quality of life questionnaire. Poster presented at the ISOQOL 2nd Annual Conference; October 1995. Montreal, Canada. [abstract] Qual Life Res. 1995 Oct; 4(5):387-506. Previously presented at the British Society for Investigative Dermatology Annual Meeting.

Girman CJ, Hartmaier SL, Thiboutot D, Johnson J, Barber B, Demuro-Mercon C. Development of an acne-specific quality of life questionnaire. Poster presented at the British Society for Investigative Dermatology Annual Meeting; April 1995. [abstract] Br J Dermatol. 1995 Apr; 132(4):631-60. doi: 10.1111/j.1365-2133.1995.tb08724.x

Doyle V, Pearson R, Wolowacz SE, McTaggart S. An investigation of the growth of human dermal fibroblasts on poly-l-lactic acid in vitro. Presented at the European Society for Biomaterials Meeting; 1995. Porto, Portugal.